| Description |
1 online resource (iii, 40 pages). |
|
text file |
| Series |
S. hrg. ; 115-851
|
|
United States. Congress. Senate.
S. hrg. ; 115-851.
|
| Note |
Access ID (govinfo): CHRG-115shrg32387. |
|
GPO Cataloging Record Distribution Program (CRDP). |
| Bibliography |
Includes bibliographical references. |
| Performer |
Hearing witnesses: Dant, Mark, Chair, EveryLife Foundation for Rare Diseases, Louisville, KY; Patterson, Marc, M.D., Professor of Neurology, Pediatrics, and Medical Genetics, Mayo Clinic, Rochester, MN; Strupp, Michael, M.D., Professor of Neurology, University of Munich, Munich, DE; Tsang, Lincoln, F.R.Pharm.S., Partner, Arnold and Porter, Kaye, Scholer, LLP, London, England, UK; Factor, Mallory, Founder and CEO, IntraBio, Inc., Oxford, England, UK. |
| Event |
Date of hearing: 2018-10-03. |
| Subject |
Rare diseases -- Treatment.
|
|
Rare diseases. |
|
Orphan drugs.
|
|
Orphan drugs. |
|
Drug approval.
|
|
Drug approval. |
|
United States. Food and Drug Administration -- Rules and practice.
|
|
United States. Food and Drug Administration. |
|
Parliamentary practice. |
| Genre/Form |
Legislative hearings.
|
|
Rules.
|
|
Legislative hearings.
|
| Other Form: |
Microfiche version: United States. Congress. Senate. Committee on Health, Education, Labor, and Pensions. Subcommittee on Children and Families. Rare diseases (OCoLC)1294302094 |
|
Print version: United States. Congress. Senate. Committee on Health, Education, Labor, and Pensions. Subcommittee on Children and Families. Rare diseases (DLC) 2020419206 (OCoLC)1202808473 |
| Standard No. |
32-387 (GPO jacket number) |
| Gpo Item No. |
1043-C (online) |
| Sudoc No. |
Y 4.L 11/4:S.HRG.115-851 |
|
